| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/21/2001 | EP1083925A1 Acrosomal sperm protein and uses thereof |
| 03/21/2001 | EP1083923A1 Acrp30r1: a homolog of acrp30 (30 kd adipocyte complement-related protein) |
| 03/21/2001 | EP1083922A2 Composition and method for treatment of pseudomonas |
| 03/21/2001 | EP1083916A1 IL-6/sIL-6R COMPLEX FOR PROMOTION OF LIVER FUNCTIONS |
| 03/21/2001 | EP1083910A1 nrdE |
| 03/21/2001 | EP1083909A1 hCEPR RECEPTOR |
| 03/21/2001 | EP0797678B1 Hybrid adenovirus-aav virus and method of use thereof |
| 03/21/2001 | EP0734529B1 Methods and materials for the detection of staphylococcus aureus |
| 03/21/2001 | EP0547201B1 Phagemide for screening antibodies |
| 03/21/2001 | EP0539518B1 Methods of identifying compounds that act as agonists or antagonists for proteins involved in signal transduction |
| 03/21/2001 | CN1288057A Coded novel human angiotensin II-1 receptor related protein gene, and application and prepn. method therefor |
| 03/21/2001 | CN1288056A Novel human coagulation thrombus protein-1 media factor, the application and prepn. method therefor |
| 03/21/2001 | CN1063489C Novel polypeptide and DNA coding for the same |
| 03/20/2001 | US6205404 DNA-binding proteins of the zinc-finger class |
| 03/20/2001 | US6204435 Nucleotide sequences which code insect poison; for biological pest control |
| 03/20/2001 | US6204432 PA28 modified transgenic mice |
| 03/20/2001 | US6204374 Cell cycle regulatory gene |
| 03/20/2001 | US6204373 Plant promoters |
| 03/20/2001 | US6204372 DNA encoding a human tubby homolog |
| 03/20/2001 | US6204371 Compositions and methods for the treatment and diagnosis of immune disorders |
| 03/20/2001 | US6204370 MN gene and protein |
| 03/20/2001 | US6204367 Elisa kit for quantification of C-terminal telopeptides of type I collagen in human serum |
| 03/20/2001 | US6204366 Specific binding agents |
| 03/20/2001 | US6204365 Collagen modulators for use in photoablation eximer laser keratectomy |
| 03/20/2001 | US6204364 Cell growth factor; for the treatment of cell proliferation and differentiation defects |
| 03/20/2001 | US6204362 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 03/20/2001 | US6204361 Method of peptide synthesis |
| 03/20/2001 | US6204360 Peptide; for the treatment of viral, neoplastic and immunological diseases |
| 03/20/2001 | US6204359 Form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 03/20/2001 | US6204326 Adding peptide nucleic acid units to an amine terminated peptide nucleic acid oligomer on a solid phase synthetic resin; biosynthesis |
| 03/20/2001 | US6204252 Granulocytic ehrlichiosis is an acute, potentially fatal tick-borne infection. |
| 03/20/2001 | US6204250 Immunization of infants |
| 03/20/2001 | US6204247 Reacting a leptin with 0.5-5 fold molar excess of edta dianhydride to to form a monomer or dimer |
| 03/20/2001 | US6204246 Derived from bacillus thuringiensis insecticidal crystal proteins. |
| 03/20/2001 | US6204241 Polypeptides found in vertebrate species, which polypeptides are mitogenic growth factors for glial cells, including schwann cells. |
| 03/20/2001 | US6204232 As detergent additive |
| 03/20/2001 | US6204063 Nucleotide sequences coding mitochondrial polypeptide; for controlling metabolism in plants |
| 03/20/2001 | US6204061 Culturing cells with adjusted nucleotide sequences; transform cells with vector, detect cell with genome adjustment, propagate cells |
| 03/20/2001 | US6204059 AAV capsid vehicles for molecular transfer |
| 03/20/2001 | US6204057 Polynucleotides and the proteins encoded thereby, suitable for controlling lamellicorn beetles |
| 03/20/2001 | US6204054 Transcytosis vehicles and enchancers for drug delivery |
| 03/20/2001 | US6204052 Nucleotide sequence associated with preferential gene expression; for use in cancer gene therapy and treatment of autoimmune diseases or infections |
| 03/20/2001 | US6204047 Growth differentiation factor-10 |
| 03/20/2001 | US6204045 Genetically engineered infectious laryngotracheitis virus; for the development of vaccines against viral disease |
| 03/20/2001 | US6204044 Capsid protein; for the detection and prevention of viral infection |
| 03/20/2001 | US6204042 Isolated polynucleotide segment |
| 03/20/2001 | US6204038 Desaturase antigen of Mycobacterium tuberculosis |
| 03/20/2001 | US6204035 Enzymatic protein associated with modulation of coagulation; for preparing tissues, and organs for grafting; anticoauglant; for diagnosis of defective coagulation in humans; for treating autoimmune and inflammatory diseases |
| 03/20/2001 | US6204023 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 03/20/2001 | US6204022 Low-toxicity human interferon-alpha analogs |
| 03/20/2001 | US6204021 Amino acid and nucleotide sequences; hybridization probes; recombinant production; diagnosis, prevention, and treatment of nervous system disorders; anticarcinogenic agents; antiinflammatory/antifertility agents; immunosuppressants |
| 03/20/2001 | US6204020 DNA encoding N∇2 CSF-1 (short form) and carboxy truncated fragment thereof |
| 03/20/2001 | US6204018 66 kDa antigen from Borrelia |
| 03/20/2001 | US6204017 Polynucleotide encoding a histamine receptor |
| 03/20/2001 | US6204016 Tyrosylprotein sulfotransferases and methods of use thereof |
| 03/20/2001 | US6204013 Nucleotide sequence of myocardium secreted protein-5; recombinant production; drug screening; therapy of congestive heart failure; probes; primers; antibodies |
| 03/20/2001 | US6204011 Human receptor tyrosine kinase, KDR |
| 03/20/2001 | US6204009 Nucleic acids encoding mutant recombinant hemoglobins containing heme pocket mutations |
| 03/20/2001 | US6204008 Bioprocess for production of dipeptide based compounds |
| 03/20/2001 | US6204003 Methods for the diagnosis of feline infectious anemia |
| 03/20/2001 | US6204001 Methods for determining compounds capable of inhibiting the activities of the Ha-Ras oncongene |
| 03/20/2001 | US6204000 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 |
| 03/20/2001 | US6203998 Human dopamine receptor and its uses |
| 03/20/2001 | US6203995 Agouti-related transcript antibodies and methods of use |
| 03/20/2001 | US6203986 Visualization of RNA in living cells |
| 03/20/2001 | US6203980 Identification of apolipoprotein H mutations and their diagnostic uses |
| 03/20/2001 | US6203976 Drug screening using eukaryotic cells with dna construct of regulatory sequence and promoter linked to reporter gene, contacting with chemical, quantitatively determining signal produced, comparing to controls, then mixing with carrier |
| 03/20/2001 | US6203801 Coccidiosis polypeptide and vaccines |
| 03/20/2001 | US6203800 Screening for antibacterial agents; genetic engineering |
| 03/20/2001 | US6203799 Cholera vaccines; deleted mutant strain |
| 03/20/2001 | US6203798 Lyme disease diagnosis and vaccines; genetic engineering |
| 03/20/2001 | US6203795 Polypeptide; antibody h23 recognizes tumor antigen expressed on breast cancer cells |
| 03/20/2001 | US6203794 Botulinum or tetanus toxin conjugated to drug; treating neurvous system and muscular disorders |
| 03/20/2001 | US6203792 Composition and methods using myelin-associated glycoprotein (MAG) and inhibitors thereof |
| 03/20/2001 | US6203789 Treating erythrocytes with s-nitroso-cysteine, homocysteine, or cysteinylglycine to reduce blood pressure |
| 03/20/2001 | US6203788 Implanting cellular adhesion molecule and schwann or oligodendrocyte progenitor cell(s); inhibiting n-cadherin-mediated cell adhesion; treating muliple sclerosis |
| 03/20/2001 | CA2098303C Synthetic bioadhesive polypeptide |
| 03/20/2001 | CA1341207C Analogues of insulin-like growth factor-1 |
| 03/20/2001 | CA1341206C Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them |
| 03/17/2001 | CA2281913A1 A vaccine against piscirickettsia salmonis based on a recombinant 17 kd protein |
| 03/15/2001 | WO2001018845A1 Method of determining etch endpoint using principal components analysis of optical emission spectra |
| 03/15/2001 | WO2001018547A1 Essential genes and assays relating thereto |
| 03/15/2001 | WO2001018546A2 Screening for inhibitors of 'paired helical filaments' |
| 03/15/2001 | WO2001018542A2 Identification, assessment, prevention, and therapy of ovarian cancer |
| 03/15/2001 | WO2001018254A2 Mutant of rad51 gene and its use in the diagnosis of predisposition to breast cancer |
| 03/15/2001 | WO2001018250A2 Single nucleotide polymorphisms in genes |
| 03/15/2001 | WO2001018249A1 Staphylococcus aureus kdtb polynucleotide and polypeptide |
| 03/15/2001 | WO2001018248A2 Quorum sensing signaling in bacteria |
| 03/15/2001 | WO2001018236A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | WO2001018234A1 Method to identify gene function using small molecule probes |
| 03/15/2001 | WO2001018228A1 HUMAN sbgFGF-10a |
| 03/15/2001 | WO2001018223A1 Paramyxoviruses having modified transcription initiation sequence |
| 03/15/2001 | WO2001018221A1 Nucleic and amino acid sequences relating to resistance to blackleg in plants |
| 03/15/2001 | WO2001018219A1 Regulatory sequences functioning in filamentous fungi |
| 03/15/2001 | WO2001018212A2 Mycobacterium paratuberculosis-specific antigens and their diagnostic uses |
| 03/15/2001 | WO2001018211A1 Sugarcane plant promoters to express heterologous nucleic acids |
| 03/15/2001 | WO2001018210A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | WO2001018209A1 Fibroblast growth factor polypeptide and nucleic acids encoding same |
| 03/15/2001 | WO2001018208A2 Interferon induced polynucleotides and proteins encoded thereby |
| 03/15/2001 | WO2001018207A1 Human 7tm proteins receptors and polynucleotides encoding the same |